BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3927715)

  • 1. Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases.
    Giroux L; Bettez P; Giroux L
    Am J Kidney Dis; 1985 Jul; 6(1):28-39. PubMed ID: 3927715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin-induced hemolytic-uremic syndrome.
    Proia AD; Harden EA; Silberman HR
    Arch Pathol Lab Med; 1984 Dec; 108(12):959-62. PubMed ID: 6210069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
    Cordonnier D; Vert-Pré FC; Bayle F; Alix JL; Couderc P
    Nephrologie; 1985; 6(1):19-26. PubMed ID: 3923381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin C associated hemolytic uremic syndrome.
    Jain S; Seymour AE
    Pathology; 1987 Jan; 19(1):58-61. PubMed ID: 3108839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis.
    Garibotto G; Acquarone N; Saffioti S; Deferrari G; Villaggio B; Ferrario F
    Nephron; 1989; 51(3):409-12. PubMed ID: 2493141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
    Yasunaga C; Komota T; Mimura K; Kinjyo M; Sueishi K; Hirose T
    Gan No Rinsho; 1987 Jun; 33(7):854-60. PubMed ID: 3112442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
    Crocker J; Jones EL
    J Clin Pathol; 1983 Jan; 36(1):24-9. PubMed ID: 6401771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin C-induced hemolytic uremic syndrome. Six case reports and review of the literature on renal, pulmonary and cardiac side effects of the drug.
    Verweij J; van der Burg ME; Pinedo HM
    Radiother Oncol; 1987 Jan; 8(1):33-41. PubMed ID: 3101142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitomycin C-induced pulmonary and renal toxicities.
    Loprinzi CL
    Wis Med J; 1984 Mar; 83(3):16-7. PubMed ID: 6428065
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitomycin--C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: cumulative toxicity of an old drug in a new era.
    El-Ghazal R; Podoltsev N; Marks P; Chu E; Saif MW
    Clin Colorectal Cancer; 2011 Jun; 10(2):142-5. PubMed ID: 21859568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery from mitomycin C-induced hemolytic uremic syndrome. A case report.
    Verwey J; Boven E; van der Meulen J; Pinedo HM
    Cancer; 1984 Dec; 54(12):2878-81. PubMed ID: 6437662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.
    Lesesne JB; Rothschild N; Erickson B; Korec S; Sisk R; Keller J; Arbus M; Woolley PV; Chiazze L; Schein PS
    J Clin Oncol; 1989 Jun; 7(6):781-9. PubMed ID: 2497229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
    Mergenthaler HG; Binsack T; Wilmanns W
    Oncology; 1988; 45(1):11-4. PubMed ID: 3124028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycin C-related hemolytic uremic syndrome in cancer patients.
    Schiebe ME; Hoffmann W; Belka C; Bamberg M
    Anticancer Drugs; 1998 Jun; 9(5):433-5. PubMed ID: 9660541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
    Sheldon R; Slaughter D
    Cancer; 1986 Oct; 58(7):1428-36. PubMed ID: 3091244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
    Anai H; Okada Y; Okubo K; Korenaga D; Maehara Y; Sugimachi K; Ohi Y
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1487-91. PubMed ID: 2120375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitomycin-induced hemolytic-uremic syndrome. Successful treatment with corticosteroids and intense plasma exchange.
    Lyman NW; Michaelson R; Viscuso RL; Winn R; Mulgaonakar S; Jacobs MG
    Arch Intern Med; 1983 Aug; 143(8):1617-8. PubMed ID: 6870446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitomycin-induced hemolytic uremic kidney. An experimental model in the rat.
    Cattell V
    Am J Pathol; 1985 Oct; 121(1):88-95. PubMed ID: 3876775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.